Patient Reported Outcomes Following Percutaneous Lung Ablation
ConditionLung Neoplasm
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
This study evaluates satisfaction with percutaneous ablation and any symptoms experienced before and after the procedure in patients with lung tumors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Undergoing percutaneous lung ablation
Disqualifiers
Decline to participate in research
Trial population
Adult patients undergoing percutaneous lung ablation recruited from Mayo Clinic in Rochester
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Non-Interventional Study
Other interventionNon-interventional study
Treatment groups
50 Participants
are divided into 1 treatment groupGroup A: Observational1 intervention
Trial outcomes
Primary outcomes
1
Symptom severity following percutaneous lung ablation
Assessed using a study-specific survey. Participants evaluate 5 symptoms (pain, fatigue, drowsiness, shortness of breath, and disturbed sleep), each on an 11-point Likert scale of 0-10 where 0=absence of symptoms and 10=as bas as you can imagine. Higher scores indicate greater severity of symptoms.
Time frame
Baseline (prior to ablation), 1 day, 3 days, 7 days, 1 month, 3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: